Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07449637) titled 'Real-World Treatment Patterns and Survival Outcomes in Patients With Intermed... Read More
Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07449949) titled 'A Single-Arm Study on the Efficacy of Sequential Chemoradiotherapy Followed b... Read More
Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07450872) titled 'Symptom Cluster Heterogeneity and Gut Microbiota Mechanisms in Childhood Canc... Read More
Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07451145) titled 'Stress Reduction Program for Iraqi Medical Students' on Feb. 27. Study Type:... Read More
Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07451197) titled 'Family-Focused Study to Support Medication for Opioid Use Disorder' on Feb. 2... Read More
Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07453004) titled 'A Study to Evaluate the Efficacy,Safety,Tolerability,Pharmacokinetics,and Imm... Read More
Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ISRCTN78570937) titled 'Peer support - head and neck cancer' on Feb. 27. Study Type: Observationa... Read More
Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07449819) titled 'Neural Mobilization to Improve Chronic Musculoskeletal Pain in Older Adults' ... Read More
Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07449910) titled 'Safety and Efficacy of Baricitinib After Endovascular Treatment in Acute Ante... Read More
Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07449923) titled 'CAPRI: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EY... Read More